Interestingly, ID1 ablation in a mouse transgenic glioblastoma model failed to render these cells non-tumorigenic; in fact, ID1 loss appeared to enhance tumor growth and shorten latency to end point29. The gene discussed is ID1; the disease is glioblastoma.